Pulished Date October, 2018
ID: 772
Share on
Share on

North America Cervical Cancer Diagnostics And Therapeutics Market By Diagnostics Test (Pap Smear Test, HPV Testing, Colposcopy, Cervical Cancer Biopsy), By Methods (molecular Method, Cytopathological Method, Physical Method), By Therapies (surgery, Radiation Therapy, Chemotherapy And Others), By End-users (hospitals, Laboratories, Independent Physicians, Clinics, And Others), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 772
Pages: 140

The North America Cervical Cancer Diagnostics and Therapeutics market has been estimated at USD 1275.7 Million in 2018 and is projected to reach USD 1544.64 Million by 2023, at a CAGR of 3.90% during the forecast period from 2016 to 2021.  Cervical cancer was once one of the most common causes of cancer death for American women. But over the last 40 years, the cervical cancer death rate has gone down by more than 50%. The main reason for this change was the increased use of the Pap test. This screening procedure can find changes in the cervix before cancer develops. It can also find cervical cancer early − in its most curable stage.

The North American market for Cervical Cancer Diagnostics and Therapeutics is mainly driven due to increasing prevalence of human papillomavirus infected patients and increasing awareness in people about cancer and cancer treatments. However, high costs of tests and uncertain reimbursement rates are constraining the market growth in this region.

North America market for Cervical Cancer Diagnostics and Therapeutics is segmented based on diagnostics test, methods, end-users and therapies. By Diagnostics test, the market is further sub-segmented into Pap smear test, HPV testing, colposcopy, cervical cancer biopsy. By methods, the market is further sub-segmented into molecular method, cytopathological method, physical method. By therapies, the market is further sub-segmented into surgery, radiation therapy, chemotherapy and others. By end-users, the market is further sub-segmented into hospitals, laboratories, independent physicians, clinics, and others. Pap smear test segment dominated the market by Diagnostic test, holding a 45% share in the global market for cervical cancer diagnostic tests. The high growth rate of this segment can be attributed to the high efficiency of the test, low cost of the test in comparison with other tests available in the market, and rising awareness regarding cancer diagnosis. 

 

Geographically, North America market for Cervical Cancer Diagnostics and Therapeutics is segmented into U.S. and Canada. A number of factors such as rising prevalence of cervical cancer, growing awareness of cervical cancer screening programs, and government support are driving the growth of the HPV testing market in the North American region.

Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, EDP Biotech, Epigenomics AG, Exact Sciences, Fujirebio, Genomic Tree, Metabiomics, Oncocyte (Biotime), Quest Diagnostics, Randox Laboratories, Siemens Healthcare, Volition Rx, are the major players of North America Cervical Cancer Diagnostics and Therapeutics market.

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By diagnostics test                 

                             5.1.1 Pap smear test     

                             5.1.2 HPV testing           

                             5.1.3 Colposcopy           

                             5.1.4 Cervical cancer biopsy      

              5.2 By methods                            

                             5.2.1 Molecular method             

                             5.2.2 Cytopathological method 

                             5.2.3 Physical method  

              5.3 By therapies                           

                             5.3.1 Surgery    

                             5.3.2 Radiation therapy

                             5.3.3 Chemotherapy     

                             5.3.4 Other therapies   

              5.4 By end-users                          

                             5.4.1 Hospitals 

                             5.4.2 Laboratories         

                             5.4.3 Independent physicians   

                             5.4.4 Clinics      

                             5.4.5 Other end-users  

6. Geographical Analysis                                         

                             6.1 Introduction             

                             6.2 United States           

                             6.3 Canada       

7. Pipeline Product Analysis                                    

              7.1 Overview                  

              7.2 Pipeline Development Landscape                   

              7.3 Molecular Targets in the Pipeline                   

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target    

8. Strategic Analysis                                   

              8.1 PESTLE analysis                      

                             8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9. Market Leaders' Analysis                                    

              9.1 Abbott Diagnostics                

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 Alere                          

              9.3 Beckman Coulter                   

              9.4 Clinical Genomics                  

              9.5 Companion Dx                       

              9.6 EDP Biotech              

              9.7 Epigenomics AG                     

              9.8 Exact Sciences                        

              9.9 Fujirebio                    

              9.10 Genomic Tree                      

              9.11 Metabiomics                        

              9.12 Siemens Healthcare                          

10. Competitive Landscape                                     

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11. Expert Opinions                                   

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  2. North America Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2018-2023 (USD Million)
  3. North America Cervical Cancer Pap smear test Market By Region, From 2018-2023 (USD Million)
  4. North America Cervical Cancer HPV testing Market By Region, From 2018-2023 (USD Million)
  5. North America Cervical Cancer Colposcopy Market By Region, From 2018-2023 (USD Million)
  6. North America Cervical cancer biopsy Market By Region, From 2018-2023 (USD Million)
  7. North America Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2018-2023 (USD Million)
  8. North America Molecular method Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  9. North America Cytopathological method Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  10. North America Physical method Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  11. North America Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2018-2023 (USD Million)
  12. North America Surgery Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  13. North America Radiation therapy Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  14. North America Chemotherapy Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  15. North America Other therapies Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  16. North America Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2018-2023 (USD Million)
  17. North America Hospitals Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  18. North America Laboratories Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  19. North America Independent physicians Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  20. North America Clinics Cervical Cancer Diagnostics and Therapeutics Market By Region, From 2018-2023 (USD Million)
  21. North America Other end-users Market By Region, From 2018-2023 (USD Million)
  22. United States Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2018-2023 (USD Million)
  23. United States Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2018-2023 (USD Million)
  24. United States Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2018-2023 (USD Million)
  25. United States Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2018-2023 (USD Million)
  26. Canada Cervical Cancer Diagnostics and Therapeutics Market By Diagnostics test, From 2018-2023 (USD Million)
  27. Canada Cervical Cancer Diagnostics and Therapeutics Market By Methods, From 2018-2023 (USD Million)
  28. Canada Cervical Cancer Diagnostics and Therapeutics Market By Therapies, From 2018-2023 (USD Million)
  29. Canada Cervical Cancer Diagnostics and Therapeutics Market By End-users, From 2018-2023 (USD Million)

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients